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We have previously adapted an experimental system which supports autonomous replication of human papillomavirus-
11 (HPV-11) genomic DNA in a human squamous carcinoma cell line (SCC-4) following electroporation of linearized viral
DNA. This system allows evaluation of HPV-11 transcription in the context of replicating viral genomes. RNA was isolated
from cells following transfection, and first-strand cDNA was produced by reverse transcription using HPV-11-specific
primers. The cDNAs were amplified using the polymerase chain reaction, and resulting DNA products were cloned and
sequenced. Transcripts were identified that utilize the same splice donor and acceptor sites as transcripts characterized
previously from human lesions. Three previously unreported splice junctions that employ novel combinations of those splice
sites were also identified. We also detected these newly identified transcripts in laryngeal papillomas. A modified version
of the 5* rapid amplification of cDNA ends method was used to identify transcriptional start sites of several of the HPV-11
transcripts. The family of mRNAs characterized in this replication system have the potential to encode all of the major HPV-
11 E-region proteins described to date. The data support the utility of this system as an experimental model for examining
mechanisms of viral replication and transcription. q 1996 Academic Press, Inc.
INTRODUCTION (Chow et al., 1987). Further studies employing PCR
(Chiang et al., 1991; Rotenberg et al., 1989b), cDNA clon-
Papillomaviruses are small, nonenveloped, DNA vi- ing (Nasseri et al., 1987), nuclease mapping (Smotkin et
ruses that infect mammals in a species- and host cell- al., 1989; DiLorenzo and Steinberg, 1995), and retrovirus-
specific manner. Nearly 70 different genotypes of hu- mediated gene transfer (Chiang et al., 1991; Rotenberg
man papillomaviruses (HPVs) have been isolated (de et al., 1989a) confirmed the structures of these transcripts
Villiers, 1994). The genomic DNAs of several HPV types and identified additional mRNAs, some of which utilize
have been cloned and characterized. HPV genomes nonconsensus splice sites.
consist of a double-stranded, circular DNA of about Information from these studies has been useful in ex-
7900 bp, which can be divided into three regions: the amining the role of various HPV-11 proteins in viral repli-
long control region, containing cis-acting genetic ele- cation and transcription. For example, experiments em-
ments; the early region (E-region), which contains ploying the use of expression vectors to produce HPV-
genes expressed in nonproductively infected cells; and 11 proteins from heterologous promoters demonstrated
the late region (L-region), containing genes that are that the E1 and E2 proteins were necessary and sufficient
expressed only in productively infected cells (for re- for DNA replication (Chiang et al., 1992). However, due to
views, see Chow and Broker, 1994; Howley, 1990; zur the lack of an in vitro system permissive to autonomous
Hausen and de Villiers, 1994).
replication of HPV-11 DNA, these studies could not ad-
One of the most-studied human papillomaviruses is
dress the roles of HPV-11 gene products in the context
HPV-11 (Dartmann et al., 1986) which is associated with
of the replicating viral genome.
condylomata acuminata (genital warts) and respiratory
Identification and accurate mapping of each mRNApapillomatosis. Various groups have made use of the
species are crucial for understanding the roles of viralHPV-11 cDNA (Gissmann et al., 1982) to identify and
gene products in replication and transcription, as wellcharacterize a number of HPV-11 transcripts. Electron-
as how the expression of these products is regulated. Amicroscopic R-loop studies of human condyloma mRNA,
thorough characterization of the transcripts expressedin conjunction with an examination of the HPV-11 se-
from autonomously replicating viral DNA is especiallyquence for the presence of consensus splice sites, pro-
important because some of the viral gene productsvided the first descriptions of HPV-11 mRNA structure
function as regulatory proteins in transcription and rep-
lication.
Until recently, no culture system had been available1 To whom correspondence and reprint requests should be ad-
dressed. Fax: (619) 931-0209; E-mail: lcowsert@isisph.com. in which to study HPV-11 DNA replication and transcrip-
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tion in the context of the viral genome. Del Vecchio et 52.5 mM KCl, 1 mM MgCl2 , 200 mM dNTPs, 10 pmol of
each HPV-11-specific primer, and 2 U AmpliTaq DNAal. (1992) demonstrated that HPV-11 DNA can replicate
autonomously when transfected into cultured SCC-4 polymerase (Perkin – Elmer Corporation, Norwalk, CT).
Amplification of cDNA was performed in a Perkin – El-cells. We have adapted this system to study the effects
of antiviral compounds on HPV-11 DNA replication mer DNA thermal cycler as follows. Incubation was at
947 for 5 min; 35 cycles of denaturation for 1 min at 947,(P. R. Clark and L. M. Cowsert, manuscript submitted for
publication). In order to further investigate the effects of annealing for 30 sec at 577, elongation for 2 min at 727;
and incubation at 727 for 10 min.these compounds on viral transcription, we needed to
identify and characterize the mRNA species expressed Amplification products were visualized on a 3% aga-
rose gel and isolated from gel slices by purification onin this system.
Since the full productive functions of HPV-11, includ- glass powder (Vogelstein and Gillespie, 1979). In some
cases, 10% of the isolated PCR product was reamplifieding transcription of L-region genes, are only expressed
in terminally differentiated keratinocytes, this study fo- using the same PCR primers, and the product(s) of the
second amplification was gel purified for cloning. Thecuses on E-region transcripts. We report the expression
of HPV-11 transcripts encoding all of the major E-region cDNAs were ligated into Bluescript vector (Stratagene,
La Jolla, CA) by utilizing restriction enzyme sites encodedproteins in SCC-4 cells containing autonomously repli-
cating HPV-11 DNA. The nucleotide sequences span- in the linker sequences of the PCR primers. Plasmid DNA
was prepared by the alkaline lysis method (Sambrook etning splice junctions of the transcripts were determined
from cDNAs derived from viral mRNAs. Transcriptional al., 1989), purified on a silica membrane spin column
(GlassMAX; Gibco-BRL), and sequenced using thestart sites for some of the transcripts were mapped.
Novel transcripts identified in our system were con- Sequenase Version 2.0 DNA sequencing kit (Amersham
Life Sciences, Arlington Heights, IL), according to thefirmed to be expressed in vivo. The results support the
use of this system as a model for investigating HPV-11 manufacturer’s instructions. Samples were separated on
a 6% polyacrylamide gel containing 8 M urea. For eachE-region gene expression.
cDNA, the nucleotide sequence spanning the splice junc-
tion was determined, including at least 50 bp on eachMATERIALS AND METHODS
side of the junction site.
Transfections and RNA isolation
Isolation of cDNAs by 5*-RACE
Linearized full-length HPV-11 genomic DNA obtained
To isolate cDNAs containing transcriptional start sitesby excision from the plasmid pUC19 (Yanisch-Perron et
of HPV-11 transcripts, the 5*-RACE system for rapid am-al., 1985) was transfected into human squamous carci-
plification of cDNA ends (Gibco-BRL) was used, withnoma (SCC-4) cells by electroporation, as described by
modifications based on a procedure described by Ba¨hr-Del Vecchio et al. (1992). Total RNA was isolated from
ing et al. (1994). Briefly, 10 mg of total RNA was reversetransfected cells by the guanidine isothiocyanate method
transcribed using an HPV-11-specific primer according(Chirgwin et al., 1979). RNA was suspended in RNase-
to the manufacturer’s instructions. The first-strand cDNAfree water and stored at 0807. Laryngeal papilloma bi-
was treated with 2 U Escherichia coli RNase H for 10opsy specimens were a generous gift from Dr. Bettie
min at 557 to remove bound template and purified onSteinberg (Long Island Jewish Medical Center). RNA was
GlassMAX columns. Twenty to fifty percent of the first-prepared from sample homogenates by the same method
strand cDNA was tailed with oligo(dG) by incubation withused for transfected cells.
15 U terminal deoxynucleotidyl transferase and 200 mM
dGTP in 20 mM Tris–HCl, pH 8.4, 50 mM KCl, 1.5 mMIsolation of cDNAs by RT-PCR
MgCl2 for 10 min at 377. Twenty to forty-five percent of the
dG-tailed cDNA was amplified by PCR using an oligo(dC)Ten micrograms of total RNA from HPV-11-electro-
porated SCC-4 cells was annealed with 2.5 pmol of an linker primer and an HPV-11-specific primer. The 50-ml
reaction mixture contained 20 mM Tris–HCl, pH 8.4, 50HPV-11-specific oligonucleotide (Operon Technolo-
gies, Alameda, CA; see Table 1 for sequences) at 707 mM KCl, 1 mM MgCl2 , 200 mM dNTPs, 10 pmol of each
primer, and 2 U AmpliTaq DNA polymerase. The cyclingfor 10 min. Reverse transcription was carried out in a
20-ml reaction volume with 200 U Superscript II reverse protocol was performed as described for the isolation
of cDNAs by RT-PCR. PCR products were isolated fromtranscriptase (Gibco-BRL Life Technologies, Gaithers-
burg, MD), 500 mM dNTPs, in 50 mM Tris – HCl, pH 8.3, agarose gels, cloned, and sequenced as described
above.75 mM KCl, 3 mM MgCl2 , and 10 mM DTT, at 427 for 1
hr. The reaction was stopped by incubation at 707 for
RT-PCR gel analysis15 min. Five microliters was used directly for each am-
plification reaction in a total volume of 50 ml. The final Total RNA from HPV-11-transfected SCC-4 cells or la-
ryngeal papilloma biopsy specimens was incubated inreaction mixture contained 23 mM Tris – HCl, pH 8.4,
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TABLE 1
Oligonucleotide Primers for Generation of cDNAs
Speciesa Primerb Sequencec Nucleotides
i, vii RT 3156 5*-CATGAGTCGTTGTCCTGCAG-3* 3156–3137
dC-linker 5*-gcagatctcgagccccccccccccccc-3* NAd
DN 3109 5*-cggaattcCATTACATTGTCTTCACAGC-3* 3109–3090
ii, iii RT 3800 5*-CCACCTTATGCCTAATGGTG-3* 3800–3781
UP 347 5*-ccatcgatTGCTGCATATGCACCTACAG-3* 347–366
DN 3751 5*-cggaattcCTGACGTTGTTCCTCACTGC-3* 3751–3732
iv RT 3156 5*-CATGAGTCGTTGTCCTGCAG-3* 3156–3137
UP 1231 5*-gcagatctGACAGTGGATATGGCTATTC-3* 1231–1250
DN 3109 5*-cggaattcCATTACATTGTCTTCACAGC-3* 3109–3090
v, vi RT 3800 5*-CCACCTTATGCCTAATGGTG-3* 3800–3781
UP 1231 5*-gcagatctGACAGTGGATATGGCTATTC-3* 1231–1250
DN 3751 5*-cggaattcCTGACGTTGTTCCTCACTGC-3* 3751–3732
viii, ix RT 3800 5*-CCACCTTATGCCTAATGGTG-3* 3800–3781
dC-linker 5*-gcagatctcgagccccccccccccccc-3* NA
DN 3751 5*-cggaattcCTGACGTTGTTCCTCACTGC-3* 3751–3732
zA RT 846 5*-TGAATCGTCCGCCATCCTTG-3* 846–827
dC-linker 5*-gcagatctcgagcccccccccccccc-3* NA
DN 816 5*-cggaattcGGTGCGCAGATGGGACACAC-3* 816–797
zB RT 585 5*-TCAGGAGGCTGCAGGTCTAG-3* 585–566
dC-linker 5*-gcagatctcgagccccccccccccccc-* NA
DN 551 5*-cggaattcGGGTAACAAGTCTTCCATGC-3* 551–532
a Structure of mRNAs illustrated in Fig. 1.
b RT, primers used to produce first-strand cDNA; UP and DN, primers used in amplification step for cDNAs generated by RT-PCR; dC-linker and
DN, primers used in amplification step for cDNAs generated by 5*-RACE.
c Uppercase letters indicate HPV-11 sequences; lowercase letters indicate ‘‘linker’’ sequences that contain recognition sites for EcoRI or BglII
restriction enzymes.
d Not applicable.
10 mM Tris–HCl, pH 8.0, 1 mM EDTA, 10 mM MgCl2 , 2672); DN 3109 (see Table 1); DN 3367, 5*-GGTGTATGT-
AGTAGGTTCAG-3* (nts 3367–3348); DN 3405, 5*-GTG-and either 0.2 units/ml DNase I (Boehringer Mannheim)
or 10 ng/ml RNase (Boehringer Mannheim) at 377 for 1 CAGGCGGACACTGTAGG-3* (nts 3405–3386); and DN
3751 (see Table 1).hr. The samples were then subjected to reverse tran-
scription and PCR amplification as described above for
the isolation of cDNAs by RT-PCR. Samples from amplifi- RESULTS
cation reactions were electrophoresed in 2.5% agarose
gels or 8% polyacrylamide gels and the DNA products To characterize the E-region HPV-11 mRNAs ex-
pressed in SCC-4 cells containing transiently replicatingwere visualized by ethidium bromide staining. In some
instances, where the amount of PCR product was not HPV-11 DNA, we used RT-PCR or 5*-RACE to generate
HPV-11 cDNAs from transfected SCC-4 cell RNA. Thesufficient to be visualized by ethidium bromide staining,
the products were analyzed by Southern blotting using RT-PCR and 5*-RACE products were ligated into a clon-
ing vector and sequenced to determine the splice junc-an HPV-11 genomic DNA probe. Oligonucleotide primers
used for RT-PCR were as follows, with ‘‘RT’’ designating tions contained in the transcripts from which the cDNAs
were obtained. Sequence data from cDNAs obtained bya primer used for reverse transcription, ‘‘UP’’ designating
an ‘‘upstream’’ PCR primer (complementary to the anti- 5*-RACE additionally provided information on transcrip-
tional start sites. Figure 1 depicts the mRNA speciessense strand of HPV-11), and ‘‘DN’’ designating a ‘‘down-
stream’’ PCR primer (complementary to the sense strand identified using these procedures. Table 1 lists the prim-
ers used in the reverse transcription and amplificationof HPV-11). RT 3156 (see Table 1); RT 3681, 5*-CAATGC-
CACGTTGAAGATGC-3* [nucleotides (nts) 3681–3662]; steps.
Transcripts were identified that contain splice junc-RT 3800 (see Table 1); UP 109, 5*-GTAAAGATGCCTCCA-
CGTCT-3* (nts 109–128); UP 114, 5*-GATGCCTCCACG- tions utilizing all possible combinations of the splice do-
nors at nt 847, nt 1272, and nt 1459 with the splice ac-TCTGCAAC-3* (nts 114– 133); UP 821, 5*-CCATAACAA-
GGATGGCGGAC-3* (nts 821–840); UP 1231 (see Table ceptors at nt 2622, nt 3325, and nt 3377. Each of these
splice donor and acceptor sites has been described pre-1); UP 1381, 5*-GACAGCACCCGAGAGCATGC-3*; DN
2691, 5*-GCTGGACGACAGTCTTTCAA-3* (nts 2691 – viously from in vivo or retrovirus-mediated gene transfer
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FIG. 1. Summary of HPV-11 mRNA structures. (Top) Open reading frames in the early region of the HPV-11 genome. (Bottom) Structures of mRNAs
detected in the transfected SCC-4 cells. Roman numerals i–x are used to designate transcripts according to splice junction, with letter subscripts
used to distinguish transcripts containing the same splice junction but with 5*-exons of different lengths. Each mRNA species is represented by a
line, with splice junctions indicated by a break in the line and nucleotide locations of splice donor and acceptor sites shown. Transcriptional start
sites are depicted as solid circles with nucleotide positions indicated. Dotted lines are drawn at the 5*-ends of transcripts for which transcriptional
start sites were not determined, indicating the relative lengths of the 5*-exons as determined by RT-PCR agarose gel analysis. Solid portions of
the lines represent regions encompassed in cDNAs and consequently sequenced. Dashed lines at the 3*-ends show putative structure beyond the
downstream PCR primer, with the arrowhead located at the early poly(A) site, the presumed termination site for these transcripts. Coding potentials
indicate the open reading frames contained in each transcript. (All transcripts also contain the E5a and E5b ORFs.) References refer to identification
of similar transcripts by other methods: 1, Chiang et al., 1991; 2, Chow et al., 1987; 3, DiLorenzo and Steinberg, 1995; 4, Nasseri et al., 1987; 5,
Rotenberg et al., 1989a; 6, Rotenberg et al., 1989b; 7, Smotkin et al., 1989; *, novel transcript (not previously identified).
studies (Chiang et al., 1991; Chow et al., 1987; Nasseri of the newly identified splice junction combinations from
the transfected cells is also detected in the laryngealet al., 1987; Rotenberg et al., 1989a,b). However, not all
combinations of these donors and acceptors had been papilloma, confirming that the novel mRNAs are tran-
scribed in vivo. Because the PCR methods used in thisreported before now. Splice junctions that have been
previously described include 847ò2622, 847ò3325, study are not quantitative, no conclusions can be drawn
regarding the relative levels of expression of the various847ò3377, 1272ò3325, 1272ò3377, and 1459ò3325 (refer-
ences indicated in Fig. 1). Transcripts containing splice transcripts.
Several of the cDNAs from transfected SCC-4 cellsjunctions 1272ò2622, 1459ò2622, or 1459ò3377 have not
been previously identified. were obtained by the modified 5*-RACE method de-
scribed under Materials and Methods. The 5*-ends ofTo verify that the novel transcripts are not an artifact
of the transient replication system, we wanted to deter- these cDNAs were sequenced to identify the transcrip-
tional start sites of the corresponding mRNAs (Fig. 3).mine if these splice junction combinations are also uti-
lized by HPV-11 transcripts in vivo. Figure 2 shows the These transcripts are depicted in Fig. 1 with solid circles
at their 5*-ends.results of gel analysis of RT-PCR products from
transfected SCC-4 cells and laryngeal papillomas. Each Sequence data for the 5*-RACE cDNAs are shown in
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FIG. 2. Analysis of transcript expression by RT-PCR. Total RNA was isolated from nontransfected (control) and transfected SCC-4 cells and a
laryngeal papilloma specimen. The RNA samples were treated with DNase (D), RNase (R), or no enzyme (n), and subjected to RT-PCR as described
under Materials and Methods. Transcript structures are depicted as described in Fig. 1. The nucleotide locations of oligonucleotide primers used
for PCR amplification are indicated above the arrows. The lengths of the resulting PCR products include ‘‘linker’’ sequences contained in some of
the primers. (A) Amplification products were separated on an agarose gel and analyzed by Southern blotting using an HPV-11 genomic probe. (B)
Amplification products were separated on a polyacrylamide gel and visualized by ethidium bromide staining.
Fig. 3. The first several bands at the bottom of each gel annealed to the oligo(dG) tail of the HPV-11 first-strand
cDNA. Following this is a G that is found in neither theimage indicate sequence derived from the linker portion
of the dC-linker primer. The stretch of consecutive Cs primer nor the HPV-11 sequence. This is followed by
HPV-11 sequence. The G between the dC-linker andis derived from the portion of the dC-linker primer that
FIG. 3. Identification of transcriptional start sites from cDNAs generated using a modified 5*-RACE method. cDNAs were cloned and sequenced
as described under Materials and Methods. Gels are numbered according to the corresponding transcript illustrated in Fig. 1. Nucleotide positions
of start sites are indicated. Alternate transcriptional start sites not shown here are as follows: for 1459ò2622 splice, nts 1363, 1372, 1374, and 1416;
for 1459ò3325 splice, nts 1372, 1374, and 1378. Images of sequencing gels were scanned on a Molecular Dynamics Model 400E PhosphorImager
using ImageQuant software.
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HPV-11 sequences is presumed to be derived from the RT-PCR method are defined by the upstream primers
used in the amplification steps. To determine if tran-7-methylguanosine (m7G) cap of the RNA transcript, indi-
cating that the first nucleotide of the HPV-11 sequence scripts contained additional 5*-sequences upstream of
the PCR primer location, we used each of our upstreamcorresponds to a transcriptional start site. This method
has previously been used to map other transcriptional PCR primers with each downstream primer (see Materi-
als and Methods) to generate RT-PCR products fromstart sites (Ba¨hring et al., 1994; Hirzmann et al., 1993).
The 5*-RACE cDNA sequences reveal the presence of transfected SCC-4 cell RNA. The presence or absence
of amplification products from each combination, as welltranscripts with the following structures: a transcriptional
start site at nt 743 and a splice junction at 847ò2622 (iA); as the product sizes, was analyzed by gel electrophore-
sis to determine the most 5* sequences we could detecta transcriptional start site at nt 1416 and a splice junction
at 1459ò2622 (viiA); a transcriptional start site at nt 1374 for each transcript. The results from these analyses are
included in Fig. 1.and a splice junction at 1459ò3325 (viiiA); and a transcrip-
tional start site at 1374 and a splice junction at The 3*-ends of all of the cDNAs we isolated are defined
by the downstream primers used in the PCR reactions.1459ò3377 (ixA). No additional cDNAs containing the
847ò2622 or the 1459ò3377 splice junction were ob- We assume that the transcripts from which our cDNAs
were derived extend to the early poly(A) site describedtained by 5*-RACE. Multiple cDNAs were isolated that
contained the other two splice junctions, and several of in previous studies (Chow et al., 1987; Nasseri et al.,
1987), located around nt 4400. Figure 1 shows the openthese had transcriptional start sites that varied slightly
from those shown in Fig. 3. For example, we sequenced reading frames (ORFs) contained in each transcript, as-
suming each has its 3*-end at nt 4400. As discussedfive cDNAs containing the 1459ò3325 splice junction.
Three of these had a transcriptional start site at nt 1374, below, the translation efficiency of an ORF in a multicis-
tronic transcript depends upon its position relative toone at nt 1372, and one at nt 1378. These start sites
have not been previously identified and could indicate other ORFs. We would expect, then, that not all of the
ORFs listed would be expressed from every transcript.the presence of a novel promotor.
Figure 3 (zA) provides data that may indicate a tran-
scriptional start site at nt 445. However, the HPV-11 se- DISCUSSION
quence contains a G at nt position 444. It follows that
the G in the 5*-RACE cDNA sequence located after the We have shown that alternatively processed E-region
mRNAs are expressed in cultured SCC-4 cells autono-string of Cs could be derived either from a m7G cap or
from the G at nt 444 in the HPV-11 sequence. We re- mously replicating HPV-11 DNA. It is important to note
that these transcripts were produced in the context ofpeated the isolation of cDNAs by 5*-RACE and se-
quenced a total of eight cDNAs that had 5*-ends identical the HPV-11 viral genome alone, without cotransfection
of regulatory protein expression vectors.to that shown in Fig. 3 (zA). Still, due to the presence of
a G at nt 444 in the HPV-11 sequence, we cannot state Due to the very low abundance of many HPV-11
mRNAs expressed both in tissues and in the culturedconclusively that nt 445 is a transcriptional start site
based on 5*-RACE cDNA sequence data alone. Other SCC-4 cells, detection by Northern blot techniques is
not practical. The long stretches of sequence shared bygroups have identified HPV-11 transcripts initiating at the
E7 promotor, with transcriptional start sites at around nt different transcripts further complicate attempts to distin-
guish between the mRNAs by methods such as Northern260 (DiLorenzo and Steinberg, 1995; Smotkin et al., 1989).
We are currently employing other experimental methods analysis and ribonuclease protection assay. We there-
fore characterized the HPV-11 transcripts using PCR am-to confirm the presence of E7 transcripts with an alter-
nate start site at nt 445. plification techniques. Although the use of HPV-11-spe-
cific primers for the generation of first-strand cDNA willThe data in Fig. 3 (zB) indicate that a mRNA species
with a transcriptional start site at nt 94 is expressed in necessarily bias the resulting products, our primer
choice and use of multiple combinations of primers wereour system. This is in agreement with R-loop, RNase
protection, and S1/ExoVII mapping studies (Chin et al., designed to maximize the detection of any transcripts
derived from the E-region of the viral genome. Indeed,1989; Chow et al., 1987; Smotkin et al., 1989) that identi-
fied a transcriptional start at nt 100, nt 99, and nt 90, using these methods in the SCC-4 transfection system,
we detected transcripts that had not been previouslyrespectively. Our cDNA contained only sequences from
nt 94 to nt 551, due to the design of the downstream identified by any of the methods utilized by other groups.
Still, it is possible that additional E-region mRNA speciesHPV-11-specific PCR primer, so the transcript from which
it was derived could have contained any one of the splice exist that were not detected by our methods.
HPV-11 transcripts were characterized by sequencingjunctions we identified.
cDNAs isolated by the modified 5*-RACE method en- cDNAs obtained by RT-PCR or by a modified 5*-RACE
method. Splice junctions were determined from cDNAsabled us to map transcriptional start sites as described
above. However, the 5*-ends of cDNAs obtained by the obtained by both methods, while use of the 5*-RACE
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method also enabled identification of transcriptional start The HPV-11 transcripts had 5*-ends located within the
E1 ORF. Likewise, in our studies, none of the transcriptssites. From these data, we have demonstrated that the
transfected SCC-4 cells express every major E-region containing the 1272ò3325 splice junction had 5*-se-
quences that included the E1 AUG. It appears, then, thattranscript previously found in human condylomas. Novel
transcripts identified in our system were found to be the newly identified species iv may be the only HPV-11
transcript that can express E1M. Species vii is the firstexpressed in laryngeal papillomas.
Several groups have employed various methods to transcript identified that encodes the E1Ma protein. An
E1MaòE4 fusion protein could be translated from spe-characterize HPV-11 mRNAs. Many of these studies
characterized transcripts from human condylomata cies viiiB . This transcript was identified by Chiang et al.
(1991) as a cDNA obtained by retrovirus-mediated gene(Chiang et al., 1991; Chow et al., 1987; Nasseri et al.,
1987; Rotenberg et al., 1989b; Smotkin et al., 1989) or transfer. However, we did not detect a transcript encod-
ing the E1MòE2C fusion protein also described bylaryngeal papillomas (DiLorenzo and Steinberg, 1995).
Others used retrovirus-mediated gene transfer to identify Chiang et al. (1991). Species vi contains the 1272ò3377
splice junction found in their cDNA but does not containpossible splice junctions (Chiang et al., 1991; Rotenberg
et al., 1989a). The results presented here indicate that 5*-sequences extending beyond the start of the E1 ORF.
Further studies to precisely map the transcriptional startthe mRNAs expressed in transfected SCC-4 cells utilize
the same splice donors and acceptors as had been iden- sites of these transcripts will be necessary to resolve
whether an E1MòE2C transcript is expressed in thetified from these previous studies. Our data demonstrate
the presence of transcripts containing splice junctions transfected cells in the context of the HPV-11 viral ge-
nome.that utilize all possible combinations of the splice donor
sites at nts 847, 1272, and 1459 with the splice acceptor We identified four transcripts in this system that could
express the E2 transactivator. Two of these contain thesites at nts 2622, 3325, and 3377. Six of these splice
junctions have been previously identified while three 847ò2622 splice junction, but with different-sized 5*-ex-
ons. Species iB encodes the E6 and E7 proteins in addi-have not. The novel transcripts were confirmed by RT-
PCR analysis to be expressed in laryngeal papillomas, tion to E2. Based on studies of translation from papillo-
mavirus mRNAs with multiple open reading frames (Bar-demonstrating that these transcripts are not unique to
the culture system used in this study. bosa and Wettstein, 1988a,b; Iftner et al., 1990), we would
not expect the E7 protein to be translated from thisThe family of mRNAs characterized in the transient
replication system have the potential to encode all of the mRNA. The shorter species, iA , would express only the
E2 protein. These two mRNAs have each been foundmajor HPV-11 E-region proteins described to date, with
the exception of an E1MòE2C fusion protein. Moreover, in human condylomas and by retrovirus-mediated gene
transfer (Chow et al., 1987; Rotenberg et al., 1989a,b).with the identification of new transcriptional start sites
and splice junctions, we have discovered mRNAs that Full-length E2 could also be translated from the novel
species iv, assuming that reinitiation of translation oc-encode proteins such as E2Ca and E5a without the pres-
ence of other upstream ORFs. As discussed below, this curs after translation of E1M. The relative positions of the
E1M termination codon and the E2 AUG in this transcriptset of transcripts encodes every E-region protein, with
minimal redundancy and seldom requiring reinitiation of should allow for efficient reinitiation of translation (Kozak,
1987; Peabody and Berg, 1986; Peabody et al., 1986).translation.
The E1 and E2 proteins are necessary for viral replica- The fourth E2 mRNA (viiA) appears to be transcribed from
a novel promoter and contains the novel splice junctiontion (Chiang et al., 1992; Del Vecchio et al., 1992), so we
would expect to find transcripts encoding these proteins 1459ò2622. This transcript and species iA differ only in
their approximately 100-bp 5*-exons, which contain un-in this system. Although we did not identify an E1-specific
promoter, the full-length E1 protein could be expressed translated sequences. It is intriguing to speculate that
E2 is translated primarily from these two species (iA andfrom a transcript with the E6 or E7 promoter. We did
detect a transcript by RT-PCR (x) that includes nts 821 – viiA), and that the expression of the two transcripts is
differentially regulated by their particular promoters.3109 with no splice junction, thus containing the entire
E1 ORF. Three other mRNAs encode N-terminal portions Two E2C repressor proteins have been described for
bovine papillomavirus (Choe et al., 1989; Hubbert et al.,of the E1 ORF. Two short E1 proteins, E1M and E1Ma,
and an E1òE4 fusion protein could be translated from 1988; Lambert et al., 1989, 1987), but until now, only one
had been identified for HPV-11 (Rotenberg et al., 1989b).species iv, viiB , and viiiB , respectively. The 1272
ò2622
splice junction contained in species iv has not been pre- We have detected a transcript encoding E2C (species v),
containing the same splice junction as previously identi-viously reported. By R-loop mapping of HPV-6 RNA prepa-
rations, Chow et al. (1987) identified a transcript with the fied by R-loop mapping and PCR cloning (Chow et al.,
1987; Rotenberg et al., 1989b). Although none of these1272ò3325 splice junction and a 5*-end near nt 700 that
would also encode the E1M protein. However, they did studies detected 5*-sequences that include the E1 AUG,
the transcriptional start for this mRNA has not been pre-not detect this transcript in HPV-11 RNA preparations.
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cisely mapped. Should the transcript indeed encode The novel promoter identified for the E5a/E5b tran-
script is also used by two other mRNAs discussed above.E1M, it would be unlikely that E2C would be expressed
efficiently from this mRNA as the relative locations of the Species viiA encodes full-length E2 with no upstream
ORFs, but uses a different promoter from the speciesE1M and E2C ORFs would probably preclude reinitiation
of translation (Kozak, 1987; Peabody and Berg, 1986; Pea- iA E2 mRNA. Species ixA encodes a novel putative E2
repressor protein, E2Ca, with no upstream ORFs. Spe-body et al., 1986). We have characterized a novel E2C
HPV-11 transcript, species ixA , that encodes a smaller C- cies viiiA encodes E5a and E5b with no upstream ORFs.
Each of these mRNAs appears to be an important mem-terminal E2 protein (E2Ca) and lacks any other upstream
ORFs. The transcript contains a 5* untranslated region ber of the set of early region transcripts expressed from
the autonomously replicating HPV-11 genome.of about 85 nt followed by an AUG located at the 3*-
end of the 5*-exon. The novel 1459ò3377 splice junction In this study we did not investigate the relative abun-
dance of different transcripts. We cannot assume thatbrings this AUG in-frame with the E2 ORF. The translated
protein would consist of the C-terminal 149 amino acids transcription in the transfection system exactly mimics
viral transcription in vivo. Indeed, HPV-11 mRNA levelsof E2 preceded by the initiator methionine. This portion
of the E2 protein is sufficient for DNA binding (Chin et are not the same even between lesions taken from differ-
ent patients. Thus, the present lack of information regard-al., 1989, 1988). The detection of these two E2-encoding
transcripts expressed from autonomously replicating ing transcript levels does not invalidate this transcription
system as a useful model for investigating HPV-11 tran-HPV-11 genomic DNA is important. In light of the fact that
we did not detect any transcripts encoding an E1MòE2C scription. Rather, we have laid the foundation for further
investigation of viral mRNA expression, by identifyingprotein, it appears that E2C and E2Ca would play a signif-
icant role in repression. three novel splice junctions and a potential novel pro-
moter. This information is crucial for the proper designThe E6 and E7 proteins are encoded in several of the
transcripts we detected in this system. Species iB , ii, and of molecular probes to assay levels of mRNA expression.
The results presented here confirm the expression ofviiB could each express the E6 protein. As mentioned
above, we would not expect the E7 protein to be trans- viral mRNA in SCC-4 cells containing autonomously repli-
cating HPV-11 DNA. The early region transcripts charac-lated from mRNAs that also contained the entire E6 ORF,
as reinitiation of translation should not occur for E7 (Bar- terized here utilize the same splice donor and acceptor
sites as transcripts identified in vivo. Examination of thebosa and Wettstein, 1988a,b). We identified a possible
E7 transcriptional start site at nt 445 (species zA). mRNAs coding potentials of the set of transcripts characterized
here indicates that all of the major early region proteinstranscribed from this promoter would not contain the
E6 ORF and consequently could express the E7 protein. could be expressed from these mRNAs. These results
support the use of this system as a valuable tool forSpecies iii might also be able to express the E7 protein,
depending on the location of the 5*-end of the transcript. examining HPV-11 viral transcription.
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